Biopolymers as promising vehicles for drug delivery to the brain

References

• Agrawal P, Singh RP, Sharma G, Mehata AK, Singh S, Rajesh CV, Pandey BL, Koch B, Muthu MS, Sonali. 2017. Bioadhesive micelles of d-α-tocopherol polyethylene glycol succinate 1000: synergism of chitosan and transferrin in targeted drug delivery. Colloids Surf B Biointerfaces. 152:277–288. doi: 10.1016/j.colsurfb.2017.01.021.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Alam MA, Ahmad FJ. 2018. Quantification and brain targeting of eugenol-loaded surface modified nanoparticles through intranasal route in the treatment of cerebral ischemia. Drug Res. 68(10):584–595. doi: 10.1055/a-0596-7288.
   PubMed Web of Science ®Google Scholar
• Aktaş Y, Yemisci M, Andrieux K, Gürsoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Riguera R, Sargon MF, et al. 2005. Development and brain delivery of chitosan − PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem. 16(6):1503–1511. doi: 10.1021/bc050217o.
   PubMed Web of Science ®Google Scholar
• Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. 2005. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx. 2(4):554–571. doi: 10.1602/neurorx.2.4.554.
   PubMedGoogle Scholar
• Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, Robertson JD, Rotello VM, Prakash YS, Mukherjee P. 2010. Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett. 10(7):2543–2548. doi: 10.1021/nl101140t.
   PubMed Web of Science ®Google Scholar
• Azadi A, Rouini MR, Hamidi M. 2015. Neuropharmacokinetic evaluation of methotrexate-loaded chitosan nanogels. Int J Biol Macromol. 79:326–335. doi: 10.1016/j.ijbiomac.2015.05.001.
   PubMed Web of Science ®Google Scholar
• Banks WA, Erickson MA. 2010. The blood–brain barrier and immune function and dysfunction. Neurobiol Dis. 37(1):26–32. doi: 10.1016/j.nbd.2009.07.031.
   PubMed Web of Science ®Google Scholar
• Barcia E, Boeva L, García-García L, Slowing K, Fernández-Carballido A, Casanova Y, Negro S. 2017. Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease. Drug Deliv. 24(1):1112–1123. doi: 10.1080/10717544.2017.1359862.
   PubMed Web of Science ®Google Scholar
• Barral JM, Broadley SA, Schaffar G, Hartl FU. 2004, February. Roles of molecular chaperones in protein misfolding diseases. In Seminars in cell & developmental biology. Academic Press; vol. 15, no. 1; p. 17–29. doi: 10.1016/j.semcdb.2003.12.010.
   Google Scholar
• Begley DJ. 2004. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther. 104(1):29–45. doi: 10.1016/j.pharmthera.2004.08.001.
   PubMed Web of Science ®Google Scholar
• Bhatia SK, Gurav R, Choi T-R, Jung H-R, Yang S-Y, Moon Y-M, Song H-S, Jeon J-M, Choi K-Y, Yang Y-H. 2019a. Bioconversion of plant biomass hydrolysate into bioplastic (polyhydroxyalkanoates) using Ralstonia eutropha 5119. Bioresour Technol. 271:306–315. doi: 10.1016/j.biortech.2018.09.122.
   PubMed Web of Science ®Google Scholar
• Bhatia SK, Gurav R, Choi T-R, Jung H-R, Yang S-Y, Song H-S, Jeon J-M, Kim J-S, Lee Y-K, Yang Y-H. 2019b. Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) production from engineered Ralstonia eutropha using synthetic and anaerobically digested food waste derived volatile fatty acids. Int J Biol Macromol. 133:1–10. doi: 10.1016/j.ijbiomac.2019.04.083.
   PubMed Web of Science ®Google Scholar
• Blasberg RG, Patlak C, Fenstermacher JD. 1975. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther. 195(1): 73–83.
   Google Scholar
• Bodor N, Buchwald P. 1999. Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems. Adv Drug Deliv Rev. 36(2–3):229–254. doi: 10.1016/s0169-409x(98)00090-8.
   PubMed Web of Science ®Google Scholar
• Bodor N, Buchwald P. 2001. Drug targeting by retrometabolic design: soft drugs and chemical delivery systems. J Recept Signal Transduct Res. 21(2–3):287–310. doi: 10.1081/rrs-100107431.
   PubMed Web of Science ®Google Scholar
• Bodor N, Kaminski JJ. 1987. Prodrugs and site-specific chemical delivery systems. Annu Rep Med Chem. 22:303–313.
   Web of Science ®Google Scholar
• Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I, Lindman S, Minogue AM, Thulin E, Walsh DM, Dawson KA, Linse S. 2008. Inhibition of amyloid β protein fibrillation by polymeric nanoparticles. J Am Chem Soc. 130(46):15437–15443.
   PubMed Web of Science ®Google Scholar
• Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I, Dawson KA, Linse S. 2010. Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci, 1(4): 279–287. doi: 10.1021/ja8041806.
   PubMed Web of Science ®Google Scholar
• Caprifico AE, Foot PJ, Polycarpou E, Calabrese G. 2020. Overcoming the blood-brain barrier: functionalised chitosan nanocarriers. Pharmaceutics. 12(11):1013. doi: 10.3390/pharmaceutics12111013.
   PubMed Web of Science ®Google Scholar
• Carra S, Alberti S, Arrigo PA, Benesch JL, Benjamin IJ, Boelens W, Bartelt-Kirbach B, Brundel BJJM, Buchner J, Bukau B, et al. 2017. The growing world of small heat shock proteins: from structure to functions. Cell Stress Chaperones. 22(4):601–611. doi: 10.1007/s12192-017-0787-8.
   PubMed Web of Science ®Google Scholar
• Carradori D, Balducci C, Re F, Brambilla D, Le Droumaguet B, Flores O, Gaudin A, Mura S, Forloni G, Ordoñez-Gutierrez L, et al. 2018. Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer’s disease-like transgenic mouse model. Nanomedicine. 14(2):609–618. doi: 10.1016/j.nano.2017.12.006.
   PubMed Web of Science ®Google Scholar
• Cerletti A, Drewe J, Fricker G, Eberle A, Huwyler J. 2000. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Target. 8(6):435–446. doi: 10.3109/10611860008997919.
   PubMed Web of Science ®Google Scholar
• Changyong C, Chae SY, Jae-Won N. 2006. Thermosensitive poly (N-isopropylacrylamide)-b-poly (-caprolactone) nanoparticles for efficient drug delivery system. Polymer. 47(13):4571–4580. doi: 10.1016/j.polymer.2006.05.011.
   Web of Science ®Google Scholar
• Chen T, Li C, Li Y, Yi X, Wang R, Lee SMY, Zheng Y. 2017. Small-sized mPEG–PLGA nanoparticles of Schisantherin A with sustained release for enhanced brain uptake and anti-parkinsonian activity. ACS Appl Mater Interfaces. 9(11):9516–9527. doi: 10.1021/acsami.7b01171.
   PubMed Web of Science ®Google Scholar
• Chu L, Wang A, Ni L, Yan X, Song Y, Zhao M, Sun K, Mu H, Liu S, Wu Z, et al. 2018. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Drug Deliv. 25(1):1634–1641. doi: 10.1080/10717544.2018.1494226.
   PubMed Web of Science ®Google Scholar
• Crivori P, Cruciani G, Carrupt PA, Testa B. 2000. Predicting blood − brain barrier permeation from three-dimensional molecular structure. J Med Chem. 43(11):2204–2216. doi: 10.1021/jm990968+.
   PubMed Web of Science ®Google Scholar
• Dabur M, Loureiro JA, Pereira MC. 2020. Fluorinated molecules and nanotechnology: future ‘avengers’ against the Alzheimer’s disease? Int J Mol Sci. 21(8):2989. doi: 10.3390/ijms21082989.
   PubMed Web of Science ®Google Scholar
• Debnath K, Shekhar S, Kumar V, Jana NR, Jana NR. 2016. Efficient inhibition of protein aggregation, disintegration of aggregates, and lowering of cytotoxicity by green tea polyphenol-based self-assembled polymer nanoparticles. ACS Appl Mater Interfaces. 8(31):20309–20318. doi: 10.1021/acsami.6b06853.
   PubMed Web of Science ®Google Scholar
• Falahati M, Attar F, Sharifi M, Haertlé T, Berret JF, Khan RH, Saboury AA. 2019. A health concern regarding the protein corona, aggregation and disaggregation. Biochim Biophys Acta Gen Subj. 1863(5):971–991. doi: 10.1016/j.bbagen.2019.02.012.
   PubMed Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, Kumar M, Baboota S, Kaur Sahni J, Ali J. 2012. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 47(1):6–15. doi: 10.1016/j.ejps.2012.04.013.
   PubMed Web of Science ®Google Scholar
• Fei LI, Perrett S. 2009. Effect of nanoparticles on protein folding and fibrillogenesis. Int J Mol Sci. 10(2):646–655. doi: 10.3390/ijms10020646.
   PubMed Web of Science ®Google Scholar
• Fernandes J, Ghate MV, Mallik SB, Lewis SA. 2018. Amino acid conjugated chitosan nanoparticles for the brain targeting of a model dipeptidyl peptidase-4 inhibitor. Int J Pharm. 547(1–2):563–571. doi: 10.1016/j.ijpharm.2018.06.031.
   PubMedGoogle Scholar
• Gajbhiye KR, Gajbhiye V, Siddiqui IA, Pilla S, Soni V. 2017. Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: an in vitro-in vivo study. Sci Rep. 7(1):11086. doi: 10.1038/s41598-017-11611-4.
   PubMedGoogle Scholar
• Gan CW, Feng SS. 2010. Transferrin-conjugated nanoparticles of poly (lactide)-D-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier. Biomaterials. 31(30):7748–7757. doi: 10.1016/j.biomaterials.2010.06.053.
   PubMed Web of Science ®Google Scholar
• Gelperina S, Maksimenko O, Khalansky A, Vanchugova L, Shipulo E, Abbasova K, Berdiev R, Wohlfart S, Chepurnova N, Kreuter J. 2010. Drug delivery to the brain using surfactant-coated poly (lactide-co-glycolide) nanoparticles: influence of the formulation parameters. Eur J Pharm Biopharm. 74(2):157–163. doi: 10.1016/j.ejpb.2009.09.003.
   PubMed Web of Science ®Google Scholar
• George T, Brady MF. 2020. Ethylenediaminetetraacetic acid (EDTA). StatPearls. StatPearls Publishing.
   Google Scholar
• Gholami L, Tafaghodi M, Abbasi B, Daroudi M, Kazemi Oskuee R. 2019. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool. J Cell Physiol. 234(2):1547–1559. doi: 10.1002/jcp.27019.
   PubMed Web of Science ®Google Scholar
• Ghosh P, De P. 2020. Modulation of amyloid protein fibrillation by synthetic polymers: recent advances in the context of neurodegenerative diseases. ACS Appl Bio Mater. 3(10):6598–6625. doi: 10.1021/acsabm.0c01021.
   PubMedGoogle Scholar
• Gronich N, Abernethy DR. 2009. Pharmacology across the aging continuum. Pharmacol Therapeut. :257–264. ISBN 9781416032915, doi:10.1016/B978-1-4160-3291-5.50023-8.
   Google Scholar
• Gu J, Al-Bayati K, Ho EA. 2017. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes. Drug Deliv Transl Res. 7(4):497–506. doi: 10.1007/s13346-017-0368-5.
   PubMed Web of Science ®Google Scholar
• Guo B, Sheng Z, Kenry K, Hu D, Lin X, Xu S, Liu C, Zheng H, Liu B. 2017. Biocompatible conjugated polymer nanoparticles for highly efficient photoacoustic imaging of orthotopic brain tumors in the second near-infrared window. Mater Horiz. 4(6):1151–1156. doi: 10.1039/C7MH00672A.
   Web of Science ®Google Scholar
• Gupta J, Fatima MT, Islam Z, Khan RH, Uversky VN, Salahuddin P. 2019. Nanoparticle formulations in the diagnosis and therapy of Alzheimer’s disease. Int J Biol Macromol. 130:515–526. doi: 10.1016/j.ijbiomac.2019.02.156.
   PubMed Web of Science ®Google Scholar
• Ha CS, Cho WJ. 2002. Miscibility, properties, and biodegradability of microbial polyester containing blends. Progress Polym Sci. 27(4):759–809. doi: 10.1016/S0079-6700(01)00050-8.
   Web of Science ®Google Scholar
• Han HK, Amidon GL. 2000. Targeted prodrug design to optimize drug delivery. AAPS PharmSci. 2(1):E6–58. doi: 10.1208/ps020106.
   PubMedGoogle Scholar
• Harbaugh RE, Saunders RL, Reeder RF. 1988. Use of implantable pumps for central nervous system drug infusions to treat neurological disease. Neurosurgery. 23(6):693–698. doi: 10.1227/00006123-198812000-00001.
   PubMed Web of Science ®Google Scholar
• Huang H, Chan J, Wittner M, Jelicks LA, Morris SA, Factor SM, Weiss LM, Braunstein VL, Bacchi CJ, Yarlett N, et al. 1999. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol. 31(1):75–88. doi: 10.1006/jmcc.1998.0848.
   PubMed Web of Science ®Google Scholar
• Huang N, Lu S, Liu XG, Zhu J, Wang YJ, Liu RT. 2017. PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer’s disease mice. Oncotarget. 8(46):81001–81013. doi: 10.18632/oncotarget.20944.
   PubMedGoogle Scholar
• Irani M, Sadeghi GMM, Haririan I. 2017. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide. Int J Biol Macromol. 97:744–751. doi: 10.1016/j.ijbiomac.2017.01.073.
   PubMed Web of Science ®Google Scholar
• Iyer M, Mishra R, Han Y, Hopfinger AJ. 2002. Predicting blood–brain barrier partitioning of organic molecules using membrane–interaction QSAR analysis. Pharm Res. 19(11):1611–1621. doi: 10.1023/a:1020792909928.
   PubMed Web of Science ®Google Scholar
• Jahromi LP, Panah FM, Azadi A, Ashrafi H. 2019. A mechanistic investigation on methotrexate-loaded chitosan-based hydrogel nanoparticles intended for CNS drug delivery: Trojan horse effect or not? Int J Biol Macromol. 125:785–790. doi: 10.1016/j.ijbiomac.2018.12.093.
   PubMed Web of Science ®Google Scholar
• Jost WH, Angersbach D. 2005. Ropinirole, a non‐ergoline dopamine agonist. CNS Drug Rev. 11(3):253–272. doi: 10.1111/j.1527-3458.2005.tb00046.x.
   PubMedGoogle Scholar
• Kale SN, Deore SL. 2016. Emulsion micro emulsion and nano emulsion: a review. SRP. 8(1):39–47. doi: 10.5530/srp.2017.1.8.
   Google Scholar
• Kaur A, Jain S, Tiwary AK. 2008. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation. Acta Pharm. 58(1):61–74. doi: 10.2478/v10007-007-0045-1.
   PubMed Web of Science ®Google Scholar
• Kaur S, Manhas P, Swami A, Bhandari R, Sharma KK, Jain R, Kumar R, Pandey SK, Kuhad A, Sharma RK, et al. 2018. Bioengineered PLGA-chitosan nanoparticles for brain targeted intranasal delivery of antiepileptic TRH analogues. Chem Eng J. 346:630–639. doi: 10.1016/j.cej.2018.03.176.
   Web of Science ®Google Scholar
• Kaye CM, Nicholls B. 2000. Clinical pharmacokinetics of ropinirole. Clin Pharmacokinet. 39(4):243–254. doi: 10.2165/00003088-200039040-00001.
   PubMed Web of Science ®Google Scholar
• Kim JY, Choi WI, Kim YH, Tae G. 2013. Brain-targeted delivery of protein using chitosan-and RVG peptide-conjugated, pluronic-based nano-carrier. Biomaterials. 34(4):1170–1178. doi: 10.1016/j.biomaterials.2012.09.047.
   PubMed Web of Science ®Google Scholar
• Klajnert B, Cortijo-Arellano M, Cladera J, Bryszewska M. 2006. Influence of dendrimer’s structure on its activity against amyloid fibril formation. Biochem Biophys Res Commun. 345(1):21–28. doi: 10.1016/j.bbrc.2006.04.041.
   PubMed Web of Science ®Google Scholar
• Kosaraju J, Gali CC, Khatwal RB, Dubala A, Chinni S, Holsinger RMD, Madhunapantula VSR, Muthureddy Nataraj SK, Basavan D. 2013. Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer’s disease. Neuropharmacology. 72:291–300. doi: 10.1016/j.neuropharm.2013.04.008.
   PubMed Web of Science ®Google Scholar
• Kou L, Hou Y, Yao Q, Guo W, Wang G, Wang M, Fu Q, He Z, Ganapathy V, Sun J. 2017. L-Carnitine-conjugated nanoparticles to promote permeation across blood–brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2. Artif Cells Nanomed Biotechnol. 46(8):1–12. doi: 10.1080/21691401.2017.1384385.
   Web of Science ®Google Scholar
• Kreuter J, Petrov VE, Kharkevich DA, Alyautdin RN. 1997. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles. J Controlled Release. 49(1):81–87. doi: 10.1016/S0168-3659(97)00061-8.
   Web of Science ®Google Scholar
• Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, von Briesen H, Begley DJ. 2003. Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res. 20(3):409–416. doi: 10.1023/a:1022604120952.
   PubMed Web of Science ®Google Scholar
• Krewson CE, Klarman ML, Saltzman WM. 1995. Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res. 680(1–2):196–206. doi: 10.1016/0006-8993(95)00261-n.
   PubMed Web of Science ®Google Scholar
• Kubek MJ, Domb AJ, Veronesi MC. 2009. Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles. Neurotherapeutics. 6(2):359–371. doi: 10.1016/j.nurt.2009.02.001.
   PubMed Web of Science ®Google Scholar
• Küçüktürkmen B, Devrim B, Saka OM, Yilmaz Ş, Arsoy T, Bozkir A. 2017. Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells. Drug Dev Ind Pharm. 43(1):12–21. doi: 10.1080/03639045.2016.1200069.
   PubMed Web of Science ®Google Scholar
• Kulkarni AD, Patel HM, Surana SJ, Vanjari YH, Belgamwar VS, Pardeshi CV. 2017. N, N, N-Trimethyl chitosan: an advanced polymer with myriad of opportunities in nanomedicine. Carbohydr Polym. 157:875–902. doi: 10.1016/j.carbpol.2016.10.041.
   PubMed Web of Science ®Google Scholar
• Kumar P, Wu H, McBride JL, Jung K-E, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N. 2007. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 448(7149):39–43. doi: 10.1038/nature05901.
   PubMed Web of Science ®Google Scholar
• Kuo YC, Tsai HC. 2018. Rosmarinic acid-and curcumin-loaded polyacrylamide-cardiolipin-poly (lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons. Mater Sci Eng C Mater Biol Appl. 91:445–457. doi: 10.1016/j.msec.2018.05.062.
   PubMed Web of Science ®Google Scholar
• Kurakhmaeva KB, Voronina TA, Kapica IG, Kreuter J, Nerobkova LN, Seredenin SB, Balabanian VY, Alyautdin RN. 2008. Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80. Bull Exp Biol Med. 145(2):259–262. doi: 10.1007/s10517-008-0065-y.
   PubMed Web of Science ®Google Scholar
• Lambert DM. 2000. Rationale and applications of lipids as prodrug carriers. Eur J Pharm Sci. 11(Suppl 2): S15–S27. doi: 10.1016/s0928-0987(00)00161-5.
   PubMedGoogle Scholar
• Lee CC, Nayak A, Sethuraman A, Belfort G, McRae GJ. 2007. A three-stage kinetic model of amyloid fibrillation. Biophys J. 92(10):3448–3458. doi: 10.1529/biophysj.106.098608.
   PubMed Web of Science ®Google Scholar
• Li H, Tong Y, Bai L, Ye L, Zhong L, Duan X, Zhu Y. 2018. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Int J Biol Macromol. 107(Pt A):204–211. doi: 10.1016/j.ijbiomac.2017.08.155.
   PubMedGoogle Scholar
• Li J, Feng L, Fan L, Zha Y, Guo L, Zhang Q, Chen J, Pang Z, Wang Y, Jiang X, et al. 2011. Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides. Biomaterials. 32(21):4943–4950. doi: 10.1016/j.biomaterials.2011.03.031.
   PubMed Web of Science ®Google Scholar
• Li S, Feng Y, Li Y, Feng W, Yoshino K. 2016. Transparent and flexible films of horizontally aligned carbon nanotube/polyimide composites with highly anisotropic mechanical, thermal, and electrical properties. Carbon. 109:131–140. doi: 10.1016/j.carbon.2016.07.052.
   Web of Science ®Google Scholar
• Liang J, Gao C, Zhu Y, Ling C, Wang Q, Huang Y, Qin J, Wang J, Lu W, Wang J. 2018. Natural brain penetration enhancer-modified albumin nanoparticles for glioma targeting delivery. ACS Appl Mater Interfaces. 10(36):30201–30213. doi: 10.1021/acsami.8b11782.
   PubMed Web of Science ®Google Scholar
• Liu JL, Li J, Zhang LY, Zhang PL, Zhou JL, Liu B. 2017. Preparation of N, N, N-trimethyl chitosan-functionalized retinoic acid-loaded lipid nanoparticles for enhanced drug delivery to glioblastoma. Trop J Pharm Res. 16(8):1765–1772. doi: 10.4314/tjpr.v16i8.3.
   Web of Science ®Google Scholar
• Liu S, Yang S, Ho PC. 2018. Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain. Asian J Pharm Sci. 13(1):72–81. doi: 10.1016/j.ajps.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Liu Z, Ren G, Zhang T, Yang Z. 2009. Action potential changes associated with the inhibitory effects on voltage-gated sodium current of hippocampal CA1 neurons by silver nanoparticles. Toxicology. 264(3):179–184. doi: 10.1016/j.tox.2009.08.005.
   PubMed Web of Science ®Google Scholar
• Livingstone JR, Spolar RS, Record MT.Jr, 1991. Contribution to the thermodynamics of protein folding from the reduction in water-accessible nonpolar surface area. Biochemistry. 30(17):4237–4244. doi: 10.1021/bi00231a019.
   PubMed Web of Science ®Google Scholar
• Loo SCJ, Moore T, Banik B, Alexis F. 2010. Biomedical applications of hydroxyapatite nanoparticles. Curr Pharm Biotechnol. 11(4):333–342. doi: 10.2174/138920110791233343.
   PubMed Web of Science ®Google Scholar
• Lotz GP, Legleiter J. 2013. The role of amyloidogenic protein oligomerization in neurodegenerative disease. J Mol Med. 91(6):653–664. doi: 10.1007/s00109-013-1025-1.
   PubMed Web of Science ®Google Scholar
• Lu CT, Zhao YZ, Wong HL, Cai J, Peng L, Tian XQ. 2014. Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine. 9:2241–2257. doi: 10.2147/IJN.S61288.
   PubMed Web of Science ®Google Scholar
• Madrid Y, Langer LF, Brem H, Langer R. 1991. New directions in the delivery of drugs and other substances to the central nervous system. Adv Pharmacol. 22:299–324.
   PubMedGoogle Scholar
• Mansur AA, Caires AJ, Carvalho SM, Capanema NS, Carvalho IC, Mansur HS. 2019. Dual-functional supramolecular nanohybrids of quantum dot/biopolymer/chemotherapeutic drug for bioimaging and killing brain cancer cells in vitro. Colloids Surf B Biointerfaces. 184:110507. doi: 10.1016/j.colsurfb.2019.110507.
   PubMed Web of Science ®Google Scholar
• Mariana A, Mara L, Valle L, Claudio D. 2012. Gum Arabic: more than an edible emulsifier. In Products and Applications of Biopolymers. InTech. doi: 10.5772/33783.
   Google Scholar
• Meesaragandla B, Karanth S, Janke U, Delcea M. 2020. Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation. Sci Rep. 10(1):7862. doi: 10.1038/s41598-020-64010-7.
   PubMed Web of Science ®Google Scholar
• Milowska K, Gabryelak T, Bryszewska M, Caminade AM, Majoral JP. 2012. Phosphorus-containing dendrimers against α-synuclein fibril formation. Int J Biol Macromol. 50(4):1138–1143. doi: 10.1016/j.ijbiomac.2012.02.003.
   PubMed Web of Science ®Google Scholar
• Milowska K, Malachowska M, Gabryelak T. 2011. PAMAM G4 dendrimers affect the aggregation of α-synuclein. Int J Biol Macromol. 48(5):742–746. doi: 10.1016/j.ijbiomac.2011.02.021.
   PubMed Web of Science ®Google Scholar
• Mittal G, Carswell H, Brett R, Currie S, Kumar MR. 2011. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer’s pathology. J Control Release. 150(2):220–228. doi: 10.1016/j.jconrel.2010.11.013.
   PubMed Web of Science ®Google Scholar
• Miura Y, Onogi S, Fukuda T. 2012. Syntheses of sulfo-glycodendrimers using click chemistry and their biological evaluation. Molecules. 17(10):11877–11896. doi: 10.3390/molecules171011877.
   PubMed Web of Science ®Google Scholar
• Mooney R, Weng Y, Garcia E, Bhojane S, Smith-Powell L, Kim SU, Annala AJ, Aboody KS, Berlin JM. 2014. Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy. J Control Release. 191:82–89. doi: 10.1016/j.jconrel.2014.06.015.
   PubMed Web of Science ®Google Scholar
• Mulik RS, Monkkonen J, Juvonen RO, Mahadik KR, Paradkar AR. 2010. ApoE3 mediated poly (butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol Pharm. 7(3):815–825. doi: 10.1021/mp900306x.
   PubMedGoogle Scholar
• Nagpal K, Singh SK, Mishra DN. 2013. Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety. Int J Biol Macromol. 59:72–83. doi: 10.1016/j.ijbiomac.2013.04.024.
   PubMed Web of Science ®Google Scholar
• Nejat H, Rabiee M, Varshochian R, Tahriri M, Jazayeri HE, Rajadas J, Ye H, Cui Z, Tayebi L. 2017. Preparation and characterization of cardamom extract-loaded gelatin nanoparticles as effective targeted drug delivery system to treat glioblastoma. React Funct Polym. 120:46–56. doi: 10.1016/j.reactfunctpolym.2017.09.008.
   Web of Science ®Google Scholar
• Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M. 2009. Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater. 8(7):543–557. doi: 10.1038/nmat2442.
   PubMed Web of Science ®Google Scholar
• Newcomb EW, Zagzag D. 2009. The murine GL261 glioma experimental model to assess novel brain tumor treatments. In CNS cancer. Humana Press; p. 227–241. Cancer Drug Discovery and Development. Humana Press. doi: 10.1007/978-1-60327-553-8_12.
   Google Scholar
• Ng KW, Khoo SPK, Heng BC, Setyawati MI, Tan EC, Zhao X, Xiong S, Fang W, Leong DT, Loo JSC. 2011. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials. 32(32):8218–8225. doi: 10.1016/j.biomaterials.2011.07.036.
   PubMed Web of Science ®Google Scholar
• Orunoğlu M, Kaffashi A, Pehlivan SB, Şahin S, Söylemezoğlu F, Oğuz KK, Mut M. 2017. Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model. Mater Sci Eng C Mater Biol Appl. 78:32–38. doi: 10.1016/j.msec.2017.03.292.
   PubMed Web of Science ®Google Scholar
• Pan L, Zhou J, Ju F, Zhu H. 2018. Intranasal delivery of α-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification. Drug Deliv Transl Res. 8(1):83–96. doi: 10.1007/s13346-017-0438-8.
   PubMed Web of Science ®Google Scholar
• Pardeshi CV, Belgamwar VS. 2016. Controlled synthesis of N, N, N-trimethyl chitosan for modulated bioadhesion and nasal membrane permeability. Int J Biol Macromol. 82:933–944. doi: 10.1016/j.ijbiomac.2015.11.012.
   PubMed Web of Science ®Google Scholar
• Pardeshi CV, Belgamwar VS. 2018. N, N, N-trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery. Int J Biol Macromol. 120(Pt B):2560–2571. doi: 10.1016/j.ijbiomac.2018.09.032.
   PubMedGoogle Scholar
• Park EJ, Yi J, Chung KH, Ryu DY, Choi J, Park K. 2008. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett. 180(3):222–229. doi: 10.1016/j.toxlet.2008.06.869.
   PubMed Web of Science ®Google Scholar
• Petri B, Bootz A, Khalansky A, Hekmatara T, Müller R, Uhl R, Kreuter J, Gelperina S. 2007. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release. 117(1):51–58. doi: 10.1016/j.jconrel.2006.10.015.
   PubMed Web of Science ®Google Scholar
• Raj R, Wairkar S, Sridhar V, Gaud R. 2018. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in vivo anti-Parkinson activity. Int J Biol Macromol. 109:27–35. doi: 10.1016/j.ijbiomac.2017.12.056.
   PubMed Web of Science ®Google Scholar
• Ramalho MJ, Sevin E, Gosselet F, Lima J, Coelho MAN, Loureiro JA, Pereira MC. 2018. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. Int J Pharm. 545(1–2):84–92. doi: 10.1016/j.ijpharm.2018.04.062.
   PubMed Web of Science ®Google Scholar
• Ray S, Sinha P, Laha B, Maiti S, Bhattacharyya UK, Nayak AK. 2018. Polysorbate 80 coated crosslinked chitosan nanoparticles of ropinirole hydrochloride for brain targeting. J Drug Delivery Sci Technol. 48:21–29. doi: 10.1016/j.jddst.2018.08.016.
   Web of Science ®Google Scholar
• Rezaie P, Khoei S, Khoee S, Shirvalilou S, Mahdavi SR. 2018. Evaluation of combined effect of hyperthermia and ionizing radiation on cytotoxic damages induced by IUdR-loaded PCL-PEG-coated magnetic nanoparticles in spheroid culture of U87MG glioblastoma cell line. Int J Radiat Biol. 94(11):1027–1037. doi: 10.1080/09553002.2018.1495855.
   PubMed Web of Science ®Google Scholar
• Rocha S, Thünemann AF, do Carmo Pereira M, Coelho M, Möhwald H, Brezesinski G. 2008. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide. Biophys Chem. 137(1):35–42. doi: 10.1016/j.bpc.2008.06.010.
   PubMed Web of Science ®Google Scholar
• Ruan C, Liu L, Lu Y, Zhang Y, He X, Chen X, Zhang Y, Chen Q, Guo Q, Sun T, et al. 2018. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma. Acta Pharm Sin B. 8(1):85–96. doi: 10.1016/j.apsb.2017.09.008.
   PubMed Web of Science ®Google Scholar
• Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. 2005. The antioxidant function of the p53 tumor suppressor. Nat Med. 11(12):1306–1313. doi: 10.1038/nm1320.
   PubMed Web of Science ®Google Scholar
• Sánchez-López E, Ettcheto M, Egea MA, Espina M, Cano A, Calpena AC, Camins A, Carmona N, Silva AM, Souto EB, et al. 2018. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization. J Nanobiotechnology. 16(1):32. doi: 10.1186/s12951-018-0356-z.
   PubMedGoogle Scholar
• Saucier-Sawyer JK, Deng Y, Seo YE, Cheng CJ, Zhang J, Quijano E, Saltzman WM. 2015. Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue. J Drug Target. 23(7–8):736–749. doi: 10.3109/1061186X.2015.1065833.
   PubMed Web of Science ®Google Scholar
• Shemetov AA, Nabiev I, Sukhanova A. 2012. Molecular interaction of proteins and peptides with nanoparticles. ACS Nano. 6(6):4585–4602. doi: 10.1021/nn300415x.
   PubMed Web of Science ®Google Scholar
• Shen Y, Cao B, Snyder NR, Woeppel KM, Eles JR, Cui XT. 2018. ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood–brain barrier. J Nanobiotechnology. 16(1):13. doi: 10.1186/s12951-018-0340-7.
   PubMedGoogle Scholar
• Sironmani A, Daniel K. 2011. Silver nanoparticles–universal multifunctional nanoparticles for bio sensing, imaging for diagnostics and targeted drug delivery for therapeutic applications. :463–484. In: Kapetanovic IM, editor. Drug discovery and development—present and future, InTech Publishers. doi: 10.5772/27047.
   Google Scholar
• Skaat H, Belfort G, Margel S. 2009. Synthesis and characterization of fluorinated magnetic core–shell nanoparticles for inhibition of insulin amyloid fibril formation. Nanotechnology. 20(22):225106. doi: 10.1088/0957-4484/20/22/225106.
   PubMed Web of Science ®Google Scholar
• Skaat H, Chen R, Grinberg I, Margel S. 2012. Engineered polymer nanoparticles containing hydrophobic dipeptide for inhibition of amyloid-β fibrillation. Biomacromolecules. 13(9):2662–2670. doi: 10.1021/bm3011177.
   PubMed Web of Science ®Google Scholar
• Smith DA, Di L, Kerns EH. 2010. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov. 9(12):929–939. doi: 10.1038/nrd3287.
   PubMed Web of Science ®Google Scholar
• Song E, Gaudin A, King AR, Seo Y-E, Suh H-W, Deng Y, Cui J, Tietjen GT, Huttner A, Saltzman WM. 2017. Surface chemistry governs cellular tropism of nanoparticles in the brain. Nat Commun. 8(1):15322. doi: 10.1038/ncomms15322.
   PubMedGoogle Scholar
• Soni S, Babbar AK, Sharma RK, Banerjee T, Maitra A. 2005. Pharmacoscintigraphic evaluation of polysorbate80-coated chitosan nanoparticles for brain targeting. Am J Drug Deliv. 3(3):205–212. doi: 10.2165/00137696-200503030-00004.
   Google Scholar
• Sukhanova A, Poly S, Shemetov A, Bronstein I, Nabiev I. 2012. Implications of protein structure instability: from physiological to pathological secondary structure. Biopolymers. 97(8):577–588. doi: 10.1002/bip.22055.
   PubMed Web of Science ®Google Scholar
• Tahara K, Miyazaki Y, Kawashima Y, Kreuter J, Yamamoto H. 2011. Brain targeting with surface-modified poly (D, L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration. Eur J Pharm Biopharm. 77(1):84–88. doi: 10.1016/j.ejpb.2010.11.002.
   PubMed Web of Science ®Google Scholar
• Takada Y, Vistica DT, Greig NH, Purdon D, Rapoport SI, Smith QR. 1992. Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. Cancer Res. 52(8):2191–2196.
   PubMed Web of Science ®Google Scholar
• Tammam SN, Azzazy HM, Lamprecht A. 2018. Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: cellular location dependent-action of lactoferrin. Eur J Pharm Biopharm. 129:74–79. doi: 10.1016/j.ejpb.2018.05.027.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Komi Y. 2015. Layers of structure and function in protein aggregation. Nat Chem Biol. 11(6):373–377. doi: 10.1038/nchembio.1818.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Frey WH. 2001. Delivery of neurotrophic factors to the central nervous system. Clin Pharmacokinet. 40(12):907–946. doi: 10.2165/00003088-200140120-00003.
   PubMed Web of Science ®Google Scholar
• Tian X-h, Wei F, Wang T-x, Wang P, Lin X-n, Wang J, Wang D, Ren L. 2012. In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain. Int J Nanomedicine. 7:1031–1041. doi: 10.2147/IJN.S26541.
   PubMed Web of Science ®Google Scholar
• Torres FG, Troncoso OP, Pisani A, Gatto F, Bardi G. 2019. Natural polysaccharide nanomaterials: an overview of their immunological properties. Int J Mol Sci. 20(20):5092. doi: 10.3390/ijms20205092.
   PubMed Web of Science ®Google Scholar
• Trapani A, De Giglio E, Cafagna D, Denora N, Agrimi G, Cassano T, Gaetani S, Cuomo V, Trapani G. 2011. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int J Pharm. 419(1–2):296–307. doi: 10.1016/j.ijpharm.2011.07.036.
   PubMed Web of Science ®Google Scholar
• Trotta V, Pavan B, Ferraro L, Beggiato S, Traini D, Des Reis LG, Scalia S, Dalpiaz A. 2018. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Eur J Pharm Biopharm. 127:250–259. doi: 10.1016/j.ejpb.2018.02.010.
   PubMed Web of Science ®Google Scholar
• Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH. 2009. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 69(22):8784–8789. doi: 10.1158/0008-5472.CAN-09-2496.
   PubMed Web of Science ®Google Scholar
• Turabee MH, Jeong TH, Ramalingam P, Kang JH, Ko YT. 2019. N, N, N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor. Carbohydr Polym. 203:302–309. doi: 10.1016/j.carbpol.2018.09.065.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmatara T, Herbert E, Kreuter J. 2009. Transferrin-and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). Eur J Pharm Biopharm. 71(2):251–256. doi: 10.1016/j.ejpb.2008.08.021.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Knobloch T, Kreuter J. 2011. Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB). J Drug Target. 19(2):125–132. doi: 10.3109/10611861003734001.
   PubMed Web of Science ®Google Scholar
• Varan C, Bilensoy E. 2017. Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment. Beilstein J Nanotechnol. 8(1):1446–1456. doi: 10.3762/bjnano.8.144.
   PubMedGoogle Scholar
• Verbeek, C. (Ed.). 2012. Products and applications of biopolymers. InTech. doi:10.5772/1802.
   Google Scholar
• Verma A, Uzun O, Hu Y, Hu Y, Han H-S, Watson N, Chen S, Irvine DJ, Stellacci F. 2008. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater. 7(7):588–595. doi: 10.1038/nmat2202.
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. 2008. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm. 70(3):735–740. doi: 10.1016/j.ejpb.2008.07.005.
   PubMed Web of Science ®Google Scholar
• Wang YY, Lai S, Suk J, Pace A, Cone R, Hanes J. 2008. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier this work was supported in part by the NIH 5U01AI066726 (RC), NIH R21HL089816 and R01EB003558 (JH), Cystic Fibrosis Foundation (HANES08G0), and fellowships from the NSF (Y.-YW) and Croucher Foundation (SKL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Angewandte Chemie-German Edition. 120(50):9872–9875. doi: 10.1002/ange.200803526.
   Google Scholar
• Wang ZH, Wang ZY, Sun CS, Wang CY, Jiang TY, Wang SL. 2010. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials. 31(5):908–915. doi: 10.1016/j.biomaterials.2009.09.104.
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, Kumar KPS, Paramakrishnan N, Suresh B. 2008. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly (n-butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm. 70(1):75–84. doi: 10.1016/j.ejpb.2008.03.009.
   PubMed Web of Science ®Google Scholar
• Wong LR, Ho PC. 2018. Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer’s disease. J Pharm Pharmacol. 70(1):59–69. doi: 10.1111/jphp.12836.
   PubMed Web of Science ®Google Scholar
• Xia H, Gao X, Gu G, Liu Z, Hu Q, Tu Y, Song Q, Yao L, Pang Z, Jiang X, et al. 2012. Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery. Int J Pharm. 436(1–2):840–850. doi: 10.1016/j.ijpharm.2012.07.029.
   PubMedGoogle Scholar
• Xu Y, Asghar S, Yang L, Li H, Wang Z, Ping Q, Xiao Y. 2017. Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma. Carbohydr Polym. 157:419–428. doi: 10.1016/j.carbpol.2016.09.085.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhou JP, Ping QN, Lu Y, Chen L. 2008. Distribution of nobiletin chitosan-based microemulsions in brain following IV injection in mice. Int J Pharm. 352(1-2):256–262. doi: 10.1016/j.ijpharm.2007.10.010.
   PubMedGoogle Scholar
• You L, Wang J, Liu T, Zhang Y, Han X, Wang T, Guo S, Dong T, Xu J, Anderson GJ, et al. 2018. Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in parkinsonian mice. ACS Nano. 12(5):4123–4139. doi: 10.1021/acsnano.7b08172.
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhang C, Guo Q, Wan X, Shao X, Liu Q, Zhang Q. 2017. Dual-functional nanoparticles for precise drug delivery to Alzheimer’s disease lesions: targeting mechanisms, pharmacodynamics and safety. Int J Pharm. 525(1):237–248. doi: 10.1016/j.ijpharm.2017.04.033.
   PubMedGoogle Scholar
• Zou L, Tao Y, Payne G, Do L, Thomas T, Rodriguez J, Dou H. 2017. Targeted delivery of nano-PTX to the brain tumor-associated macrophages. Oncotarget. 8(4):6564–6578. doi: 10.18632/oncotarget.14169.
   PubMedGoogle Scholar